Tomomi Ishihara

T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.

Akira Oku, Kiichiro Ueta, Kenji Arakawa et al. · Diabetes · 1999 · 251 citations

Novel Approach, Na+-glucose Cotransporters, Insulin Signaling +23

Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na⁺‐glucose cotransporter inhibitor T‐1095

Kenji Arakawa, Tomomi Ishihara, Akira Oku et al. · British Journal of Pharmacology · 2001 · 161 citations · Full text

C57bl/ksj‐db/db Mice, Glucose Excretion, Diabetic Syndrome +21

The interaction between vitamin A and thiazolidinedione on bovine adipocyte differentiation in primary culture.

Mariko Ohyama, Kenichi Matsuda, Shinichiro Torii et al. · Journal of Animal Science · 1998 · 86 citations

Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats

Kiichiro Ueta, Tomomi Ishihara, Yukio Matsumoto et al. · Life Sciences · 2005 · 84 citations

Metabolic Syndrome, Goto-kakizaki Rats, Medicine +9

Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARγ ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells

Yoshifumi Hida, Teruo Kawada, Shun Kayahashi et al. · Life Sciences · 1998 · 68 citations

Biochemistry, Medicine, 3T3-l1 Cells +9